Literature DB >> 12686005

Neuropsychiatric aspects of Parkinson's disease: recent advances.

Laura Marsh1, Ariel Berk.   

Abstract

Psychiatric disturbances are a common feature of Parkinson's disease (PD), which is a degenerative disorder defined by its characteristic movement abnormalities. Its management is optimal when PD is viewed as a neuropsychiatric disorder, because this encourages consideration of the motor deficits along with its psychiatric and cognitive aspects. This review addresses the diagnosis and treatment of the most common psychiatric disorders in PD, and provides an update of related clinical research, including studies on neurosurgical treatments.

Entities:  

Mesh:

Year:  2003        PMID: 12686005     DOI: 10.1007/s11920-003-0012-6

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  124 in total

1.  Transient acute depression induced by high-frequency deep-brain stimulation.

Authors:  B P Bejjani; P Damier; I Arnulf; L Thivard; A M Bonnet; D Dormont; P Cornu; B Pidoux; Y Samson; Y Agid
Journal:  N Engl J Med       Date:  1999-05-13       Impact factor: 91.245

2.  Anxiety disorders and Parkinson's disease.

Authors:  L M Iruela; V Ibañez-Rojo; I Palanca; L Caballero
Journal:  Am J Psychiatry       Date:  1992-05       Impact factor: 18.112

Review 3.  Differential diagnosis and classification of apathy.

Authors:  R S Marin
Journal:  Am J Psychiatry       Date:  1990-01       Impact factor: 18.112

4.  Increased risk of Parkinson's disease after depression: a retrospective cohort study.

Authors:  A G Schuurman; M van den Akker; K T J L Ensinck; J F M Metsemakers; J A Knottnerus; A F G Leentjens; F Buntinx
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

5.  Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.

Authors:  M Shiba; J H Bower; D M Maraganore; S K McDonnell; B J Peterson; J E Ahlskog; D J Schaid; W A Rocca
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

6.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease.

Authors:  S E Starkstein; H S Mayberg; T J Preziosi; P Andrezejewski; R Leiguarda; R G Robinson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

7.  Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.

Authors:  C G Goetz; P F Burke; S Leurgans; E Berry-Kravis; L M Blasucci; R Raman; L Zhou
Journal:  Arch Neurol       Date:  2001-02

8.  Depression in Parkinson's disease.

Authors:  S E Starkstein; T J Preziosi; P L Bolduc; R G Robinson
Journal:  J Nerv Ment Dis       Date:  1990-01       Impact factor: 2.254

9.  Depression, intellectual impairment, and Parkinson disease.

Authors:  R Mayeux; Y Stern; J Rosen; J Leventhal
Journal:  Neurology       Date:  1981-06       Impact factor: 9.910

10.  Evidence for atypical depression in Parkinson's disease.

Authors:  R B Schiffer; R Kurlan; A Rubin; S Boer
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  6 in total

1.  Neuropsychiatric phenomena associated with movement disorders.

Authors:  Joshua L Roffman; Todd Eisenberg; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

2.  MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.

Authors:  Mauricio P Cunha; Francis L Pazini; Vicente Lieberknecht; Josiane Budni; Ágatha Oliveira; Júlia M Rosa; Gianni Mancini; Leidiane Mazzardo; André R Colla; Marina C Leite; Adair R S Santos; Daniel F Martins; Andreza F de Bem; Carlos Alberto S Gonçalves; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

Review 3.  Cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy (MT); comparison of three established psychotherapies and possible common neural mechanisms of psychotherapies.

Authors:  Johannes M Dijkstra; Toshiharu Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2021-12-10       Impact factor: 3.850

4.  Prevalence of depression in Parkinson's disease patients in Ethiopia.

Authors:  Dawit Kibru Worku; Yared Mamushet Yifru; Douglas G Postels; Fikre Enquselassie Gashe
Journal:  J Clin Mov Disord       Date:  2014-12-12

Review 5.  Neuropsychiatric symptoms in untreated Parkinson's disease.

Authors:  Szabolcs Szatmari; Ben Min-Woo Illigens; Timo Siepmann; Alexandra Pinter; Annamaria Takats; Daniel Bereczki
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-16       Impact factor: 2.570

6.  Problem solving therapy for the treatment of depression for a patient with Parkinson's disease and mild cognitive impairment: a case study.

Authors:  R Scott Mackin; Patricia Areán; Alexandra Elite-Marcandonatou
Journal:  Neuropsychiatr Dis Treat       Date:  2006-09       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.